James E Flynn Insider Trading $NXTM NxStage Medical, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for James E Flynn.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of James E Flynn. James E Flynn is 10% Owner in CAS MEDICAL SYSTEMS INC ($CAMY.OB) and 10% Owner in AxoGen, Inc. ($LECT) and 10% Owner in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in STREAMLINE HEALTH SOLUTIONS INC. ($LANV) and 10% Owner in ANTARES PHARMA, INC. ($ATRS) and 10% Owner in VIA Pharmaceuticals, Inc. ($CAQ) and 10% Owner in DUSA PHARMACEUTICALS INC ($DUSA) and 10% Owner in HI TECH PHARMACAL CO INC ($HITK) and 10% Owner in AVADEL PHARMACEUTICALS PLC ($AVDL) and 10% Owner in INSPIRE PHARMACEUTICALS INC ($ISPH) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARENA PHARMACEUTICALS INC ($ARNA) and 10% Owner in ISTA PHARMACEUTICALS INC ($ISTA) and 10% Owner in MEDICINES CO /DE ($MDCO) and 10% Owner in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and Director in Talon Therapeutics, Inc. ($EMLR) and 10% Owner in LUMOS PHARMA, INC. ($NLNK) and 10% Owner in NITROMED INC ($NTMD) and 10% Owner in XENOPORT INC ($XNPT) and 10% Owner in EMAGEON INC ($EMAG) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in NeuroMetrix, Inc. ($NURO) and 10% Owner in NxStage Medical, Inc. ($NXTM) and 10% Owner in aTYR PHARMA INC ($LIFE) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and Director in PROTEON THERAPEUTICS INC ($PRTO) and 10% Owner in eHealth, Inc. ($EHTH) and 10% Owner in ZAFGEN, INC. ($ZFGN) and 10% Owner in NeurogesX Inc ($NGSX) and 10% Owner in Invuity, Inc. ($IVTY) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and 10% Owner in TriVascular Technologies, Inc. ($TRIV) and 10% Owner in Auspex Pharmaceuticals, Inc. ($ASPX) and 10% Owner in Neos Therapeutics, Inc. ($NEOS) and 10% Owner in Schrodinger, Inc. ($SDGR) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in Acutus Medical, Inc. ($AFIB) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Mallinckrodt plc ($MNK) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Adverum Biotechnologies, Inc. ($AAVL) and 10% Owner in REGENXBIO Inc. ($RGNX) and 10% Owner in Recro Pharma, Inc. ($REPH) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and Director in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in ShockWave Medical, Inc. ($SWAV) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Editas Medicine, Inc. ($EDIT) and Director in AveXis, Inc. ($AVXS) and 10% Owner in ARVINAS INC. ($ARVN) and 10% Owner in Homology Medicines, Inc. ($FIXX) and Director in Homology Medicines, Inc. ($FIXX) and Director in Oncorus, Inc. ($ONCR) and 10% Owner in Revolution Medicines, Inc. ($RVMD) and 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and 10% Owner in Frequency Therapeutics, Inc. ($FREQ) and Director in DFB Healthcare Acquisitions Corp. ($DFBH) and 10% Owner in Generation Bio Co. ($GBIO) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Cabaletta Bio, Inc. ($CABA) and 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and Director in DFP HEALTHCARE ACQUISITIONS CORP. ($DFPH) and Director in Deerfield Healthcare Technology Acquisitions Corp. ($DFHT) and 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).

James E Flynn in NxStage Medical, Inc.

Trading Symbol: NXTM
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of James E Flynn: 10% Owner
Holdings: 1,292,874 shares
Current Value: $35,916,040
Latest Transaction: Dec 15 2009
$NXTM Market Capitalization: $1.80B
$NXTM Previous Close: $27.78

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of James E Flynn in NxStage Medical, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ACRS, AFIB, DFBH, ADVM, ALIM, ALPN, ANNX, ATRS, ARNA, ARVN, LIFE, BOLD, ASPX, AVDL, AVXS, LECT, BDTX, CABA, CAMY.OB, CBIO, CNST, CYCC, CTMX, DFHTW, DFPHU, DRNA, DUSA, DVAX, EWTX, EDIT, EHTH, EMAG, FCSC, FREQ, GBIO, HITK, FIXX, ISPH, IVTY, ISTA, KNSA, LRMR, LOXO, NLNK, MNK, MDCO, MIRM, NEOS, NGSX, NURO, NTMD, NKTX, NXTM, ONCR, PRX, TARA, REPH, RGNX, RVMD, RYTM, RIGL, SDGR, SWAV, STDY, LANV, SYRS, EMLR, TERN, TWTI, TRIV, VNDA, CAQ, HOWL, XNPT, XERS

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Dec 15 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.52	13,598	102,257	1,292,874	1.3 M to 1.3 M (-1.04 %)
Dec 15 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.52	7,702	57,919	733,647	741.3 K to 733.6 K (-1.04 %)
Dec 15 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.86	18,898	148,538	1,306,472	1.3 M to 1.3 M (-1.43 %)
Dec 15 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.86	10,702	84,118	741,349	752.1 K to 741.3 K (-1.42 %)
Dec 15 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.80	20,033	156,257	1,325,370	1.3 M to 1.3 M (-1.49 %)
Dec 15 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.80	11,344	88,483	752,051	763.4 K to 752.1 K (-1.49 %)
Dec 15 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.51	6,271	47,095	1,345,403	1.4 M to 1.3 M (-0.46 %)
Dec 15 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.51	3,552	26,676	763,395	766.9 K to 763.4 K (-0.46 %)
Dec 15 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	12.74	6,565	83,638	1,351,674	1.4 M to 1.4 M (-0.48 %)
Dec 15 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	12.73	3,723	47,394	766,947	770.7 K to 766.9 K (-0.48 %)
Dec 10 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.37	11,354	83,679	1,358,239	1.4 M to 1.4 M (-0.83 %)
Dec 10 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.37	6,432	47,404	770,670	777.1 K to 770.7 K (-0.83 %)
Dec 10 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.36	2,750	20,240	1,369,593	1.4 M to 1.4 M (-0.20 %)
Dec 10 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.36	1,561	11,489	777,102	778.7 K to 777.1 K (-0.20 %)
Dec 10 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.37	20,693	152,507	1,372,343	1.4 M to 1.4 M (-1.49 %)
Dec 10 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.37	11,756	86,642	778,663	790.4 K to 778.7 K (-1.49 %)
Dec 07 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.37	18,603	137,104	1,393,036	1.4 M to 1.4 M (-1.32 %)
Dec 07 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.37	10,560	77,827	790,419	801 K to 790.4 K (-1.32 %)
Dec 07 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.37	13,184	97,166	1,411,639	1.4 M to 1.4 M (-0.93 %)
Dec 07 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.37	7,481	55,135	800,979	808.5 K to 801 K (-0.93 %)
Dec 07 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.44	99,788	742,423	1,424,823	1.5 M to 1.4 M (-6.55 %)
Dec 07 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.44	56,612	421,193	808,460	865.1 K to 808.5 K (-6.54 %)
Oct 13 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.75	4,467	30,152	1,524,611	1.5 M to 1.5 M (-0.29 %)
Oct 13 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.75	2,533	17,098	865,072	867.6 K to 865.1 K (-0.29 %)
Oct 13 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.72	2,937	19,737	1,529,078	1.5 M to 1.5 M (-0.19 %)
Oct 13 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.72	1,665	11,189	867,605	869.3 K to 867.6 K (-0.19 %)
Oct 01 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.07	2,341	16,551	1,532,015	1.5 M to 1.5 M (-0.15 %)
Oct 01 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	7.07	1,328	9,389	869,270	870.6 K to 869.3 K (-0.15 %)
Sep 23 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.76	8,932	60,380	1,534,356	1.5 M to 1.5 M (-0.58 %)
Sep 23 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.76	5,068	34,260	870,598	875.7 K to 870.6 K (-0.58 %)
Sep 23 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.72	12,229	82,179	1,543,288	1.6 M to 1.5 M (-0.79 %)
Sep 23 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.72	6,939	46,630	875,666	882.6 K to 875.7 K (-0.79 %)
Sep 23 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.72	634	4,260	1,555,517	1.6 M to 1.6 M (-0.04 %)
Sep 23 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.72	359	2,412	882,605	883 K to 882.6 K (-0.04 %)
Sep 21 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.73	23,983	161,406	1,556,151	1.6 M to 1.6 M (-1.52 %)
Sep 21 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.73	13,608	91,582	882,964	896.6 K to 883 K (-1.52 %)
Sep 21 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.74	19,695	132,744	1,580,134	1.6 M to 1.6 M (-1.23 %)
Sep 21 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.74	11,174	75,313	896,572	907.7 K to 896.6 K (-1.23 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.72	18,264	122,696	1,599,829	1.6 M to 1.6 M (-1.13 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.72	10,361	69,604	907,746	918.1 K to 907.7 K (-1.13 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.72	19,654	132,075	1,618,093	1.6 M to 1.6 M (-1.20 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.72	11,151	74,935	918,107	929.3 K to 918.1 K (-1.20 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.71	16,844	113,023	1,637,747	1.7 M to 1.6 M (-1.02 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.71	9,556	64,121	929,258	938.8 K to 929.3 K (-1.02 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.74	14,458	97,447	1,654,591	1.7 M to 1.7 M (-0.87 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.74	8,202	55,281	938,814	947 K to 938.8 K (-0.87 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.77	9,570	64,789	1,669,049	1.7 M to 1.7 M (-0.57 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.77	5,430	36,761	947,016	952.4 K to 947 K (-0.57 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.98	7,048	49,195	952,446	959.5 K to 952.4 K (-0.73 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.97	93,151	649,262	1,678,619	1.8 M to 1.7 M (-5.26 %)
Sep 16 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	6.97	2,949	20,555	959,494	962.4 K to 959.5 K (-0.31 %)
Jun 19 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	5.96	17,547	104,580	1,771,770	1.8 M to 1.8 M (-0.98 %)
Jun 19 2009	NXTM	NxStage Medical, I ...	Flynn James E	10% Owner	Sell	S	5.96	9,531	56,805	962,443	972 K to 962.4 K (-0.98 %)

Page: 1